Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fresolimumab and radiotherapy in metastatic breast cancer
NCT01401062Phase 2Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Jul 2011
- Primary completion
- Jun 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of fresolimumab in breast cancer, sponsored by Weill Cornell Medicine. Started Jul 2011; status: completed.
02
Drugs
fresolimumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01401062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01401062.